Skip to main content
. 2022 Jul 22;13:953546. doi: 10.3389/fimmu.2022.953546

Figure 4.

Figure 4

Clinical course of patient #1: Disease onset of melanoma in 2013, axillary lymph node macrometastasis in 2015, pembrolizumab initiation in 2016 because of cerebral metastasis, onset of pruritic exanthema in the end of 2017 and diagnosis of BP in 2018.